Study guide
15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease
Key Takeaways Explain This Topic AI
Functional follicular and corpus luteum cysts resolve within 1 to 2 cycles, while a mature cystic teratoma never resolves and carries about a 15 percent torsion risk.
Malignancy red flags are any complex or solid postmenopausal mass, mural nodules over 3 mm, thick irregular septations, ascites, and elevated CA-125.
Lichen sclerosus produces figure-of-eight white plaques with architectural loss and carries a 2 to 5 percent lifetime vulvar squamous cell carcinoma risk, requiring clobetasol 0.05 percent and lifelong surveillance.
Differentiated VIN arises from lichen sclerosus in older patients and carries higher progression risk than HPV-driven usual-type vulvar HSIL.
Any persistent, atypical, pigmented, ulcerated, or non-responding vulvar lesion requires a 3 to 4 mm punch biopsy rather than another empiric treatment course.
Last updated: September 2026
Benign Ovarian Masses & Malignancy Red Flags
Adnexal masses are common incidental or symptomatic findings. The midwife must differentiate physiologic functional cysts from benign neoplasms and identify malignant features requiring oncology referral. Adnexal Mass Classification & Sonographic Features
- ├── 1. Physiologic Functional Ovarian Cysts (Reproductive-Aged Women)
- │ ├── Follicular Cyst ──> Failure of Graafian follicle to rupture / ovulate
- │ │ └── Thin-walled, unilocular, anechoic, smooth margins, 3 to 8 cm
- │ │ └── NATURAL HISTORY: Spontaneous regression in 1 to 2 cycles (6-8 weeks)
- │ └── Corpus Luteum Cyst ──> Failure of corpus luteum to regress after ovulation
- │ └── Thick-walled, complex reticular echoes ("spiderweb"), peripheral "ring of fire"
- │ └── NATURAL HISTORY: Spontaneous resolution in 1 to 2 cycles; risk of rupture
- ├── 2. Benign Ovarian Neoplasms
- │ ├── Mature Cystic Teratoma (Dermoid Cyst) ──> Germ cell tumor (all 3 germ layers)
- │ │ └── Hyperechoic Rokitansky nodule, acoustic shadowing; 15% risk of torsion
- │ │ └── DOES NOT RESOLVE; Requires elective laparoscopic cystectomy
- │ ├── Serous Cystadenoma ──> Thin-walled, unilocular, clear serous fluid
- │ ├── Mucinous Cystadenoma ──> Large, multilocular, thick gelatinous mucin
- │ └── Endometrioma ("Chocolate Cyst") ──> Ectopic endometrial tissue in ovary
- │ └── Homogeneous low-level "ground-glass" echoes, absent Doppler flow
- └── 3. Red Flags for Ovarian Malignancy (Urgent Gynecologic Oncology Referral)
- ├── Postmenopausal ovarian mass (any complex or solid mass)
- ├── Solid components or mural nodularity (>3 mm)
- ├── Thick, irregular septations (>2 to 3 mm) or multilocular architecture
- ├── Ascites or peritoneal implants
- └── Elevated Serum CA-125 (>35 U/mL in postmenopausal women)
- Clinical Management of Functional Cysts vs. Dermoids
Simple Follicular Cysts (<8 cm): In an asymptomatic, premenopausal woman, a thin-walled, unilocular, anechoic cyst <8 cm is almost universally a benign physiologic follicular cyst. The standard of care is expectant management with repeat transvaginal ultrasound in 6 to 8 weeks (following 1 to 2 menses) to confirm spontaneous resolution. Combined oral contraceptives do NOT hasten the resolution of an existing cyst, though they prevent future cyst formation.
Mature Cystic Teratoma (Dermoid Cyst): Most common benign ovarian neoplasm in women <30 years old. Composed of well-differentiated ectodermal, mesodermal, and endodermal tissues (hair, sebum, teeth, calcified bone). Characterized by high lipid content, causing the ovary to float anteriorly in the pelvis, predisposing to ovarian torsion (15% risk) . Dermoid cysts never resolve spontaneously ; management is elective laparoscopic ovarian cystectomy with preservation of normal ovarian tissue.
Ovarian Torsion: A surgical emergency resulting from partial or complete twisting of the ovarian vascular pedicle. Classic presentation: sudden-onset, severe, unilateral, sharp/colicky lower abdominal and pelvic pain , accompanied by nausea and vomiting (70%). Doppler ultrasound shows enlarged, edematous ovary with absent or compromised venous and arterial flow. Requires immediate surgical detorsion and cystectomy.
Evaluating Vulvar Disease
The blueprint task "evaluates for vulvar disease" is where a great many chronic, treatable conditions are missed, usually because the vulva is inspected quickly and only in the context of a speculum exam.
Examine systematically and with light: mons, labia majora and minora, clitoral hood, vestibule, hymenal ring, perineum, and perianal skin. Note color, architecture, texture, and symmetry, and ask the patient to point to where the symptom is.
Important
If in doubt, biopsy. Any persistent, atypical, pigmented, ulcerated, indurated, or non-responding vulvar lesion warrants a 3–4 mm Keyes punch biopsy under local anesthetic. Empiric steroid or antifungal treatment of an undiagnosed vulvar lesion is the classic route to a delayed vulvar cancer diagnosis.
The Vulvar Dermatoses
Condition Appearance Key Features Treatment
Lichen sclerosus Porcelain-white, thin, crinkled "cigarette paper" plaques in a figure-of-eight around the vulva and anus Intense pruritus; architectural loss — labia minora resorption, clitoral phimosis, introital narrowing; peaks postmenopausally and in prepubertal girls; carries a 2–5% lifetime risk of vulvar squamous cell carcinoma Ultrapotent topical steroid: clobetasol propionate 0.05% ointment nightly for 4–12 weeks, then maintenance 1–3 times weekly; lifelong surveillance
Erosive lichen planus Glazed red erosions of the vestibule with a white lacy (Wickham) border; may involve the vagina and mouth Pain rather than itch; vaginal scarring and synechiae can obliterate the vagina Ultrapotent topical steroid, vaginal steroid, dilators; refer to a vulvar specialist
Lichen simplex chronicus Thickened, leathery, lichenified skin with excoriation The end product of an itch–scratch cycle , often on top of another dermatosis Mid-potency steroid, break the cycle with a sedating antihistamine at night, eliminate irritants
Contact dermatitis Diffuse erythema, sometimes with fissures Irritant from soaps, wipes, pads, laundry products, over-washing; allergic from benzocaine or fragrance Eliminate the exposure ; plain water washing; emollient; short steroid course
Vulvodynia
Chronic vulvar pain lasting 3 months or longer without an identifiable cause . The most common form is localized provoked vestibulodynia , mapped with the cotton-swab (Q-tip) test at the vestibule. Management is multimodal: pelvic floor physical therapy for the near-universal accompanying hypertonicity, topical lidocaine, tricyclics or gabapentinoids, cognitive behavioral therapy, sex therapy, and vulvar care measures. Reassure the patient that the pain is real and that a normal-appearing vulva does not mean nothing is wrong.
Neoplasia
Vulvar HSIL (usual-type VIN) is HPV-16 driven and occurs in younger patients, especially smokers.
Differentiated VIN (dVIN) arises in a background of lichen sclerosus in older patients and carries the higher progression risk — which is why lichen sclerosus requires ongoing surveillance rather than one prescription.
Vulvar squamous cell carcinoma presents as a persistent ulcer, plaque, or nodule, frequently with a long history of "yeast" treated repeatedly.
A Bartholin duct cyst or abscess in a patient over 40 should be biopsied or excised rather than simply drained, to exclude carcinoma.